S10.1: In Search of Early Diagnosis and Immunotherapeutic Strategy for Chemoresistant Ovarian Cancer in the Era of Personalized Cancer Medicine

American Journal of Reproductive Immunology - United Kingdom
doi 10.1111/aji.29_13122
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Wiley

Related search

Personalized Cancer Medicine: Era of Promise and Progress

Nature Reviews Clinical Oncology
Oncology
2011English

Personalized Cancer Medicine: Next Steps in the Genomic Era

Cellular Oncology
MedicineCancer ResearchOncologyMolecular Medicine
2015English

Personalized Therapies in the Cancer "Omics" Era

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2010English

The Importance of a Satisfactory Biopsy for the Diagnosis of Lung Cancer in the Era of Personalized Treatment

Current Oncology
Oncology
2012English

Bladder Cancer in 2011: The Dawn of Personalized Medicine

Nature Reviews Urology
Urology
2011English

An Improved Quantitative Approach for the Assessment of Mitochondrial Fragmentation in Chemoresistant Ovarian Cancer Cells

PLoS ONE
Multidisciplinary
2013English

New Era for Personalized Medicine: The Diagnosis and Management of Age-Related Macular Degeneration

Clinical and Experimental Ophthalmology
MedicineOphthalmology
2009English

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target

Frontiers in Oncology
Cancer ResearchOncology
2019English

Is There a Role of Eastern Europe in Cancer Biomarkers for Personalized Cancer Medicine?

Cancer Biomarkers
MedicineCancer ResearchOncologyGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy